IMVIONIX Acquires Commercial Rights to BEOVU from Novartis
Georgia-based ophthalmology biotechnology company IMVIONIX acquired exclusive commercial rights to BEOVU from Novartis.
Georgia-based ophthalmology biotechnology company IMVIONIX acquired exclusive commercial rights to BEOVU from Novartis.